135 related articles for article (PubMed ID: 15176946)
1. Developing an improved vaccine against tuberculosis.
McShane H
Expert Rev Vaccines; 2004 Jun; 3(3):299-306. PubMed ID: 15176946
[TBL] [Abstract][Full Text] [Related]
2. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
Wozniak TM; Ryan AA; Triccas JA; Britton WJ
Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
[TBL] [Abstract][Full Text] [Related]
3. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.
West NP; Thomson SA; Triccas JA; Medveczky CJ; Ramshaw IA; Britton WJ
Vaccine; 2011 Oct; 29(44):7759-65. PubMed ID: 21846485
[TBL] [Abstract][Full Text] [Related]
4. Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a guinea pig aerosol infection model of tuberculosis.
Vipond J; Clark SO; Hatch GJ; Vipond R; Marie Agger E; Tree JA; Williams A; Marsh PD
Tuberculosis (Edinb); 2006; 86(3-4):218-24. PubMed ID: 16520093
[TBL] [Abstract][Full Text] [Related]
5. The tuberculosis vaccine challenge.
Brennan MJ
Tuberculosis (Edinb); 2005; 85(1-2):7-12. PubMed ID: 15687021
[TBL] [Abstract][Full Text] [Related]
6. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis: vaccine and drug development.
Mitsuyama M; McMurray DN
Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S10-3. PubMed ID: 17616481
[No Abstract] [Full Text] [Related]
8. Mtb32 is a promising tuberculosis antigen for DNA vaccination in pre- and post-exposure mouse models.
Ahn SS; Jeon BY; Kim KS; Kwack JY; Lee EG; Park KS; Sung YC; Cho SN
Gene Ther; 2012 May; 19(5):570-5. PubMed ID: 21956689
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guérin vaccine.
Pinto R; Saunders BM; Camacho LR; Britton WJ; Gicquel B; Triccas JA
J Infect Dis; 2004 Jan; 189(1):105-12. PubMed ID: 14702160
[TBL] [Abstract][Full Text] [Related]
10. Identification of Novel Potential Vaccine Candidates against Tuberculosis Based on Reverse Vaccinology.
Monterrubio-López GP; González-Y-Merchand JA; Ribas-Aparicio RM
Biomed Res Int; 2015; 2015():483150. PubMed ID: 25961021
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis vaccines - an update.
Andersen P
Nat Rev Microbiol; 2007 Jul; 5(7):484-7. PubMed ID: 17571458
[No Abstract] [Full Text] [Related]
12. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
13. [Advance in DNA vaccine against Mycobacterium tuberculosis].
Wang BL; Wang HH
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):787-90. PubMed ID: 15634398
[No Abstract] [Full Text] [Related]
14. Prospects for a better vaccine against tuberculosis.
Reed SG; Alderson MR; Dalemans W; Lobet Y; Skeiky YA
Tuberculosis (Edinb); 2003; 83(1-3):213-9. PubMed ID: 12758214
[TBL] [Abstract][Full Text] [Related]
15. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
Gao H; Li K; Yu S; Xiong S
Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
[TBL] [Abstract][Full Text] [Related]
16. Novel vaccination strategies and approaches against human tuberculosis.
Méndez-Samperio P
Scand J Immunol; 2019 Aug; 90(2):e12774. PubMed ID: 31054193
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in the development and testing of vaccines against human tuberculosis.
McMurray DN
Int J Parasitol; 2003 May; 33(5-6):547-54. PubMed ID: 12782054
[TBL] [Abstract][Full Text] [Related]
18. TB vaccines: current status and future perspectives.
Aagaard C; Dietrich J; Doherty M; Andersen P
Immunol Cell Biol; 2009; 87(4):279-86. PubMed ID: 19350048
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens.
Derrick SC; Yabe IM; Yang A; Kolibab K; Hollingsworth B; Kurtz SL; Morris S
Vaccine; 2013 Sep; 31(41):4641-6. PubMed ID: 23906890
[TBL] [Abstract][Full Text] [Related]
20. Differential proteomics approach to identify putative protective antigens of Mycobacterium tuberculosis presented during early stages of macrophage infection and their evaluation as DNA vaccines.
Sharma S; Rajmani RS; Kumar A; Bhaskar A; Singh A; Manivel V; Tyagi AK; Rao KV
Indian J Exp Biol; 2015 Jul; 53(7):429-39. PubMed ID: 26245027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
